Calcium antagonists and cancer: limitations of pros and cons

J Hypertens. 1998 Aug;16(8):1101. doi: 10.1097/00004872-199816080-00003.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Calcium Channel Blockers / adverse effects*
  • Cohort Studies
  • Humans
  • Hypertension / drug therapy
  • Neoplasms / etiology*
  • Prospective Studies
  • Risk Factors
  • Safety

Substances

  • Calcium Channel Blockers